肿瘤患者-话题@MedSci

#肿瘤患者#

262篇内容 | 6370人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1424301, encodeId=2ef6142430128, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Stroke：活动性恶性肿瘤患者脑出血后血肿周围水肿特征, objectType=article, longId=183328, objectId=7d89183328d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d89183328d0, replyNumber=0, likeNumber=91, createdTime=2019-11-22, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d89183328d0, moduleTitle=Stroke：活动性恶性肿瘤患者脑出血后血肿周围水肿特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d89183328d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424300, encodeId=61da1424300b0, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=肿瘤患者治疗的“心”思考——合理选择，全程管理, objectType=article, longId=182237, objectId=369c18223ea8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=369c18223ea8, replyNumber=0, likeNumber=60, createdTime=2019-11-03, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=369c18223ea8, moduleTitle=肿瘤患者治疗的“心”思考——合理选择，全程管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=369c18223ea8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424299, encodeId=86e11424299d5, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=拜耳TRK抑制剂Vitrakvi获得欧盟批准治疗NTRK基因融合的肿瘤患者, objectType=article, longId=180106, objectId=b99c180106aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b99c180106aa, replyNumber=0, likeNumber=66, createdTime=2019-09-28, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b99c180106aa, moduleTitle=拜耳TRK抑制剂Vitrakvi获得欧盟批准治疗NTRK基因融合的肿瘤患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b99c180106aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424298, encodeId=391a142429898, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Gastroenterology：磷酸二酯酶5抑制剂的使用与良性结直肠肿瘤患者的结直肠癌风险降低有关, objectType=article, longId=178732, objectId=a09e1e87328e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a09e1e87328e, replyNumber=0, likeNumber=65, createdTime=2019-09-05, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a09e1e87328e, moduleTitle=Gastroenterology：磷酸二酯酶5抑制剂的使用与良性结直肠肿瘤患者的结直肠癌风险降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a09e1e87328e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424297, encodeId=d107142429e76, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Blood：根据15万+位血液恶性肿瘤患者绘制的家族风险图谱, objectType=article, longId=177660, objectId=255a1e7660c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=255a1e7660c6, replyNumber=0, likeNumber=76, createdTime=2019-08-16, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=255a1e7660c6, moduleTitle=Blood：根据15万+位血液恶性肿瘤患者绘制的家族风险图谱, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=255a1e7660c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424296, encodeId=5da314242968d, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=JCO：生长抑素类似物治疗晚期神经内分泌肿瘤患者的无进展生存期的预测：GETNE-TRASGU研究, objectType=article, longId=177361, objectId=414c1e7361c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=414c1e7361c0, replyNumber=0, likeNumber=72, createdTime=2019-08-11, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=414c1e7361c0, moduleTitle=JCO：生长抑素类似物治疗晚期神经内分泌肿瘤患者的无进展生存期的预测：GETNE-TRASGU研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=414c1e7361c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424295, encodeId=fccd142429520, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=J Cell Biochem：长非编码RNA预测膀胱上皮肿瘤患者生存研究, objectType=article, longId=177232, objectId=5e421e7232f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e421e7232f6, replyNumber=0, likeNumber=72, createdTime=2019-08-10, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e421e7232f6, moduleTitle=J Cell Biochem：长非编码RNA预测膀胱上皮肿瘤患者生存研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e421e7232f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424294, encodeId=d86d1424294b8, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=ESMO-WCGI大会主席说：肿瘤患者的抗凝治疗不应忽视, objectType=article, longId=175118, objectId=69fd1e5118fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69fd1e5118fd, replyNumber=0, likeNumber=84, createdTime=2019-07-12, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69fd1e5118fd, moduleTitle=ESMO-WCGI大会主席说：肿瘤患者的抗凝治疗不应忽视, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69fd1e5118fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424293, encodeId=d589142429372, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=OncoImmunology：超10万肿瘤患者大规模荟萃分析，再证TMB免疫治疗疗效预测价值！, objectType=article, longId=174899, objectId=30621e489904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30621e489904, replyNumber=0, likeNumber=81, createdTime=2019-07-07, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30621e489904, moduleTitle=OncoImmunology：超10万肿瘤患者大规模荟萃分析，再证TMB免疫治疗疗效预测价值！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30621e489904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424292, encodeId=33ab1424292c1, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=肿瘤患者静脉化疗后千万别忘了这件事, objectType=article, longId=174649, objectId=2e921e464908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e921e464908, replyNumber=0, likeNumber=87, createdTime=2019-07-03, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e921e464908, moduleTitle=肿瘤患者静脉化疗后千万别忘了这件事, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e921e464908)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424291, encodeId=53d514242911b, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=JCO：畸胎瘤对晚期生殖细胞肿瘤患者死亡率的影响, objectType=article, longId=172194, objectId=95561e21940e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95561e21940e, replyNumber=0, likeNumber=65, createdTime=2019-06-27, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95561e21940e, moduleTitle=JCO：畸胎瘤对晚期生殖细胞肿瘤患者死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95561e21940e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424290, encodeId=f2fc142429028, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=【临床心得】别对肿瘤患者说“想吃什么吃什么”, objectType=article, longId=167707, objectId=9fa916e70776, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fa916e70776, replyNumber=0, likeNumber=72, createdTime=2019-06-06, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fa916e70776, moduleTitle=【临床心得】别对肿瘤患者说“想吃什么吃什么”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fa916e70776)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424289, encodeId=a6c11424289c8, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=2019 澳大利亚共识声明：血液和恶性实体肿瘤患者免疫抑制期间乙肝病毒的管理, objectType=article, longId=166738, objectId=4792166e383a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4792166e383a, replyNumber=0, likeNumber=34, createdTime=2019-05-25, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4792166e383a, moduleTitle=2019 澳大利亚共识声明：血液和恶性实体肿瘤患者免疫抑制期间乙肝病毒的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4792166e383a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424288, encodeId=70f5142428866, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Dig Liver Dis：生长抑素类似物治疗神经内分泌肿瘤患者引起胆道结石的原因分析, objectType=article, longId=166566, objectId=c3581665668f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3581665668f, replyNumber=0, likeNumber=75, createdTime=2019-05-23, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3581665668f, moduleTitle=Dig Liver Dis：生长抑素类似物治疗神经内分泌肿瘤患者引起胆道结石的原因分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3581665668f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424287, encodeId=ef31142428e7e, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Gastroenterology：导管内乳头状粘液性肿瘤患者种系突变与癌症风险相关的患病率分析, objectType=article, longId=166286, objectId=30b016628667, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30b016628667, replyNumber=0, likeNumber=77, createdTime=2019-05-19, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30b016628667, moduleTitle=Gastroenterology：导管内乳头状粘液性肿瘤患者种系突变与癌症风险相关的患病率分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30b016628667)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424286, encodeId=8d901424286a3, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=JCO：小儿脑肿瘤患者耳毒性的认知意义, objectType=article, longId=165948, objectId=771d1659487d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=771d1659487d, replyNumber=0, likeNumber=77, createdTime=2019-05-14, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=771d1659487d, moduleTitle=JCO：小儿脑肿瘤患者耳毒性的认知意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=771d1659487d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424285, encodeId=2d1c142428543, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=崔慧娟教授：以辩证论治处理靶向药物副反应提高肿瘤患者生存质量, objectType=article, longId=165699, objectId=f87a165699c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f87a165699c7, replyNumber=0, likeNumber=90, createdTime=2019-05-10, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f87a165699c7, moduleTitle=崔慧娟教授：以辩证论治处理靶向药物副反应提高肿瘤患者生存质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f87a165699c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424284, encodeId=14b61424284aa, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=专访CSCO理事长李进：全程管理让肿瘤患者实现利益很大化, objectType=article, longId=165414, objectId=4d4f16541451, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d4f16541451, replyNumber=0, likeNumber=86, createdTime=2019-05-07, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d4f16541451, moduleTitle=专访CSCO理事长李进：全程管理让肿瘤患者实现利益很大化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d4f16541451)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424283, encodeId=3c6914242836d, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=乔贵宾教授：为解决肿瘤患者用药难、看病难，我们正一步一步做出努力, objectType=article, longId=165046, objectId=b4ec16504615, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4ec16504615, replyNumber=0, likeNumber=88, createdTime=2019-04-28, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4ec16504615, moduleTitle=乔贵宾教授：为解决肿瘤患者用药难、看病难，我们正一步一步做出努力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4ec16504615)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424282, encodeId=0af1142428203, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=肿瘤患者简明膳食自评工具的发明与研究, objectType=article, longId=164698, objectId=42ba16469896, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42ba16469896, replyNumber=0, likeNumber=65, createdTime=2019-04-22, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42ba16469896, moduleTitle=肿瘤患者简明膳食自评工具的发明与研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42ba16469896)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肿瘤患者

2020-05-29

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Stroke：活动性恶性肿瘤患者脑出血后血肿周围水肿特征

2019-11-22

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

肿瘤患者治疗的“心”思考——合理选择，全程管理

2019-11-03

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

拜耳TRK抑制剂Vitrakvi获得欧盟批准治疗NTRK基因融合的肿瘤患者

2019-09-28

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Gastroenterology：磷酸二酯酶5抑制剂的使用与良性结直肠肿瘤患者的结直肠癌风险降低有关

2019-09-05

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Blood：根据15万+位血液恶性肿瘤患者绘制的家族风险图谱

2019-08-16

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

JCO：生长抑素类似物治疗晚期神经内分泌肿瘤患者的无进展生存期的预测：GETNE-TRASGU研究

2019-08-11

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

J Cell Biochem：长非编码RNA预测膀胱上皮肿瘤患者生存研究

2019-08-10

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

ESMO-WCGI大会主席说：肿瘤患者的抗凝治疗不应忽视

2019-07-12

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

OncoImmunology：超10万肿瘤患者大规模荟萃分析，再证TMB免疫治疗疗效预测价值！

2019-07-07

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

肿瘤患者静脉化疗后千万别忘了这件事

2019-07-03

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

JCO：畸胎瘤对晚期生殖细胞肿瘤患者死亡率的影响

2019-06-27

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

【临床心得】别对肿瘤患者说“想吃什么吃什么”

2019-06-06

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

2019 澳大利亚共识声明：血液和恶性实体肿瘤患者免疫抑制期间乙肝病毒的管理

2019-05-25

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Dig Liver Dis：生长抑素类似物治疗神经内分泌肿瘤患者引起胆道结石的原因分析

2019-05-23

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Gastroenterology：导管内乳头状粘液性肿瘤患者种系突变与癌症风险相关的患病率分析

2019-05-19

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

JCO：小儿脑肿瘤患者耳毒性的认知意义

2019-05-14

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

崔慧娟教授：以辩证论治处理靶向药物副反应提高肿瘤患者生存质量

2019-05-10

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

专访CSCO理事长李进：全程管理让肿瘤患者实现利益很大化

2019-05-07

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

乔贵宾教授：为解决肿瘤患者用药难、看病难，我们正一步一步做出努力

2019-04-28

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

肿瘤患者简明膳食自评工具的发明与研究

2019-04-22

科室
- - 订阅+
  - 更多科室
工具
服务